This content is machine translated Platelet aggregation inhibition in PCI. “The flow must go on” Inhibition of coagulation is an important cornerstone of therapy for acute coronary syndrome. For this purpose, platelet aggregation inhibitors targeting thromboxane synthesis, the ADP receptor, the glycoprotein receptor IIb/IIIa and…
View Post 9 min This content is machine translated Preoperative anemia in the era of patient blood management (PBM). A pragmatic approach to diagnostics and therapy Preoperative anemia is an independent predictor of increased risk of infection, thromboembolism, and mortality. For their part, allogeneic blood transfusions further contribute to worsening outcomes through nonspecific and specific risks.…
View Post 3 min This content is machine translated Carfilzomib in relapsed multiple myeloma. New therapy option from the second therapy line Until a few years ago, the treatment of relapsed multiple myeloma was a major challenge. However, with the availability of new substances, the situation has improved significantly. Since the end…
View Post 3 min This content is machine translated Graft-versus-host disease Promising results from Hamburg For acute leukemias, allogeneic hematopoietic stem cell transplantation (HSCT) is a widely used therapeutic option with prospects of cure. An important reason for the late morbidity and mortality of HSCT…
View Post 4 min This content is machine translated Anticoagulation Procedure for special patient groups Continuing postmenopausal hormone therapy or hormone-containing contraception in women on anticoagulation seems risky. After all, hormone-containing preparations increase the risk of venous thromboembolism, which anticoagulants are intended to reduce. But…
View Post 10 min This content is machine translated "Watch and wait," radiation or systemic therapy? Diagnosis and treatment options for “indolent” non-Hodgkin’s lymphoma. The term indolent lymphomas encompasses a growing number of low-malignant non-Hodgkin lymphomas and leukemias predominantly of the B-cell series. They are differentiated and classified from each other based on their…
View Post 9 min This content is machine translated Immunothrombocytopenia A diagnosis of exclusion with many treatment options Immunothrombocytopenia (ITP) is an autoimmune disease that is frequently observed in children and adolescents as well as in people over 60 years of age. It is a diagnosis of exclusion.…
View Post 3 min This content is machine translated Neither under nor over treatment Principles of lymphoma therapy in elderly patients The elderly often cannot be treated as aggressively as younger people for cancer. But at the same time, you don’t want to deprive someone of an effective medication “just” because…
View Post 7 min This content is machine translated 57th ASH Meeting in Orlando New field of application for rituximab The ASH Congress was held last year in Orlando. This time, one of the topics was the efficacy of rituximab in adult patients with B-precursor acute lymphoblastic leukemia (ALL). Up…
View Post 6 min This content is machine translated Oncology Annual Congress in Basel Risk- and age-adapted approach to multiple myeloma In October, the annual congress of the German, Austrian and Swiss Societies of Hematology and Medical Oncology was held in Basel. A scientific symposium focused on risk- and age-adapted management…
View Post 12 min This content is machine translated Evidence base and practical considerations Anticoagulation in patients with renal insufficiency and atrial fibrillation. The risk of ischemic stroke is greatly increased in patients with renal insufficiency and atrial fibrillation. In stages II and III renal failure, DOAKs are a good alternative to vitamin…
